Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In male patients suffering from chronic pain, opioid administration induces severe hypogonadism, leading to impaired physical and psychological conditions such as fatigue, anaemia and depression. Hormone replacement therapy is rarely considered for these hypogonadic patients, notwithstanding the various pharmacological solutions available. METHODS: To treat hypogonadism and to evaluate the consequent endocrine, physical and psychological changes in male chronic pain patients treated with morphine (epidural route), we tested the administration of testosterone via a gel formulation for one year. Hormonal (total testosterone, estradiol, free testosterone, DHT, cortisol), pain (VAS and other pain questionnaires), andrological (Ageing Males' Symptoms Scale-AMS) and psychological (POMS, CES-D and SF-36) parameters were evaluated at baseline (T0) and after 3, 6 and 12 months (T3, T6, T12 respectively). RESULTS: The daily administration of testosterone increased total and free testosterone and DHT at T3, and the levels remained high until T12. Pain rating indexes (QUID) progressively improved from T3 to T12 while the other pain parameters (VAS, Area%) remained unchanged. The AMS sexual dimension and SF-36 Mental Index displayed a significant improvement over time. CONCLUSIONS: In conclusion, our results suggest that a constant, long-term supply of testosterone can induce a general improvement of the male chronic pain patient's quality of life, an important clinical aspect of pain management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“htm, according to Vermeulen’s formula [25].”
The Italian SF-36 Health Survey
Apolone, G., & Mosconi, P. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00094-8 · Cited by 1,148 · cited 12×
“In particular, the following procedures were performed during the monthly meeting: - Blood collection, - Complete clinical evaluation by the pain therapist, including the administration of specific pain questionnaires for pain assessment (VAS, QUID, Area%), - Psychological evaluation, including the administration of s…”
InfluentialOpioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656 · cited 1×
“Testosterone was replaced via a gel formulation able to restore and maintain testosterone levels [15] by virtue of the fact that its application on the skin prevents first liver clearance and allows steroids to be directly absorbed and stored in the stratum corneum.”
BackgroundThe effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564 · cited 4×
“Evidence from this study suggests that one year of testosterone replacement therapy in male patients suffering from a severe form of chronic pain and diagnosed with morphine-induced hypogonadism (OPIAD) is able to positively change hormonal and behavioural ‘indicators’ chosen to measure different aspects of their cond…”
BackgroundInfluentialEndocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
A rating system for use with patient pain drawings
Margolis, R. B., Tait, R. C., & Krause, S. J. (1986) · Pain · doi:10.1016/0304-3959(86)90026-6 · Cited by 451 · cited 1×
“The percentage of body surface area in pain (Area%) was measured according the Margolis method [18].”
MethodHypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401 · cited 1×
“For hypogonadism, there is clear evidence in the literature for both humans [3-7] and experimental animals [8,9].”
BackgroundFree testosterone and risk for Alzheimer disease in older men
Moffat, S. D., Zonderman, A. B., Metter, E. J., Kawas, C., Blackman, M. R., Harman, S. M., & Resnick, S. M. (2004) · Neurology · doi:10.1212/wnl.62.2.188 · Cited by 383
Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Migliorini, S., & Lodi, L. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01570.x · Cited by 284 · cited 1×
“In each subscale, values higher (TA, D-D, A-H, F-I and C-B) or lower (V-A) than 55 were considered significantly altered with respect to the normal population [21].”
Background
Research works printed but not linked: 2
- 10.1210/jc.85.6.2215 · DOI · Paper page
- 10.1210/jc.84.10.3666 · DOI · Paper page
Cited by
Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of Pain
Davis, M. P. (2012) · The Journal of Supportive Oncology · doi:10.1016/j.suponc.2012.05.002 · Cited by 179
“Because morphine and fentanyl reuce testosterone levels, testosterone replacement is freuently required to improve sexual function and quality of ife.(174,175) When men on buprenorphine maintenance therpy are compared with those on methadone, those on burenorphine have higher testosterone levels and less sexual ysfunc…”
BackgroundBuprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain
Pillarisetti, S., & Khanna, I. (2015) · Journal of Pain Research · doi:10.2147/jpr.s85951 · Cited by 195
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Opioid-Induced Androgen Deficiency (OPIAD)
Elliott, J. A. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es145 · Cited by 129
Basaria, S., Travison, T. G., Alford, D., Knapp, P. E., Teeter, K., Cahalan, C., Eder, R., Lakshman, K., Bachman, E., Mensing, G., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460308.86819.aa · Cited by 125
“Opioid-induced androgen deficiency is also associated with reduced quality of life.(2) Previous uncontrolled reports have shown improvement in some aspects of health-related quality of life in men receiving testosterone.”
Metadata
- Authors
- Aloisi, A., Ceccarelli, I., Carlucci, M., Suman, A., Sindaco, G., Mameli, S., Paci, V., Ravaioli, L., Passavanti, G., Bachiocco, V., & Pari, G.
- Affiliations
- University of Siena (IT)
- Ospedale Misericordia - Grosseto (IT)
- Corresponding author
- Aloisi, Anna
- Venue
- Reproductive Biology and Endocrinology
- Published
- 2011
- Volume
- 9
- Issue
- 1
- Pages
- 26
- ISSN
- 1477-7827 (ISSN-L)
- PMC
- PMC3049183
- OpenAlex
- W2102086648
- Semantic Scholar
- 29aa6f5b00bb38df6c236f99cdfdac2d8ba96a75
- Cited by
- 77
- References
- 31
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 7 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 10 · 2018: 8 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 5 · 2013: 5 · 2012: 14
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Reproductive Biology and Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Use Siena air (University of Siena) (submittedVersion, cc-by)
- Funders
- Università degli Studi di Siena
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- hormone replacement therapy, testosterone, morphine, epidural opioid administration, testosterone gel, quality of life, sexual function, androgen deprivation therapy
- MeSH terms
- Adult, Aged, Chronic Disease, Humans, Hypogonadism, Male, Middle Aged, Morphine, Pain, Prospective Studies, Quality of Life, Testosterone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients. https://app.cochat.ai/papers/10.1186/1477-7827-9-26
- The paper
- Aloisi, A., Ceccarelli, I., Carlucci, M., Suman, A., Sindaco, G., Mameli, S., Paci, V., Ravaioli, L., Passavanti, G., Bachiocco, V., & Pari, G. (2011). Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients. Reproductive Biology and Endocrinology. https://doi.org/10.1186/1477-7827-9-26
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.